ArticleWorld journal of cardiology2022

Potential for sodium-glucose cotransporter-2 inhibitors in the management of metabolic syndrome: A systematic review and meta-analysis.

Abdulbaril Olagunju et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.